Positives

• Patients on the combo commonly describe better sleep within the first month, with energy and body-composition changes emerging over 3-6 months.
  
  
• A patient reported that hot flashes and sleep fragmentation largely resolved by month two of combined dosing.
  
  

Negatives

• Patients frequently report injection-site pain, redness, and mild flushing, with occasional nausea or lightheadedness early in the cycle.
  
  
• One patient reported that the stack felt strong enough to require dose reduction to manage water retention and head pressure.
  
  

Hurdles & Side Effects

• The combination is not FDA-approved; both components fall under the contested compounding/grey-market environment described in 2024-2026 enforcement actions.
  
  
• Patients describe high ongoing cost and the same purity-verification problems documented across grey-market peptide products.